FINWIRES · TerminalLIVE
FINWIRES

PolyNovo Says US PMA Submission for NovoSorb BTM Now Expected Before 2026-End; Shares Down 4%

By

PolyNovo (ASX:PNV) said the clinical study report for its US pivotal randomized controlled trial of NovoSorb BTM has been finalized, with the premarket approval (PMA) submission now expected before the end of calendar 2026, according to a Friday Australian bourse filing.

NovoSorb, the company's polymer, is made to address unmet needs in wound care, as evidenced by its clinical adoption and patient outcomes, and the company is leveraging the technology platform to develop new products and markets, the filing said.

The company said it has proactively refined its PMA submission plan following updated Food and Drug Administration (FDA) guidance effective from February, including the sequencing of key manufacturing and validation activities, with certain activities originally planned post-submission to be included to strengthen the submission package.

The revised timing does not impact current sales or clinical use of NovoSorb products, the filing added.

The company's shares fell 4% in recent Friday trade.

Related Articles

Asia

Chasen's Profit Slips in Fiscal H2; Shares Surge 11%

Chasen (SGX:5NV) booked a 1% decline in its profit in the fiscal second half ended March 31 of SG$6.4 million, from a profit of SG$6.5 million a year earlier, according to a Thursday filing with the Singapore Exchange.Earnings per share slid to SG$0.0168 from SG$0.0181 in the year-ago period.Revenue jumped 20% year over year to SG$67.8 million from SG$56.6 million.Shares of the global integrated logistics service provider zoomed over 11% in recent trade.

SGX:5NV
Asia

Risecomm Group Enters Debt Swap Agreements With Creditors; Shares Jump 65%

Risecomm Group (HKG:1679) entered into an agreement with some creditors to issue a mix of debt and equity to settle outstanding loans, according to a Wednesday filing with the Hong Kong bourse.The power line communication products provider's shares gained 69% in late-morning trade Thursday.The firm will issue 69.8 million shares priced at HK$0.46 apiece and three-year convertible bonds worth HK$128.5 million to the creditors.The company simultaneously launched a public offering to raise funds to settle certain other loans.The firm is seeking investors for 85.9 million shares priced at HK$0.46 each, or HK$39.5 million in total, which will be used to repay loans owed to Fu Xiaoqin, a shareholder, and an entity identified as Clear Jolly.The transactions are subject to shareholder approval.

HKG:1679
Asia

Aussie Broadband Makes International Mobile Roaming Available for Mobile Customers

Aussie Broadband (ASX:ABB) said international mobile roaming is now available for Aussie Broadband mobile customers under new updates being rolled out to the MyAussie and Carbon portals, according to a statement on Thursday.Customers will be able to access 5 gigabytes of data and unlimited calls and texts for AU$5 per day when travelling in Zone 1 countries without switching or acquiring a new SIM card or provider. For customers travelling in Zone 2 and Zone 3 countries, roaming prices will be charged at pay-as-you-go rates.Customers can also choose to opt out of international mobile roaming at any time, either directly through the app or by contacting Aussie Broadband's customer service.Its shares fell 1% in recent trading on Thursday.

ASX:ABB